Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 269,470
  • Shares Outstanding, K 25,836
  • Annual Sales, $ 31,640 K
  • Annual Income, $ -940 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.25
  • Price/Sales 8.57
  • Price/Cash Flow 3,285.56
  • Price/Book 16.98

Options Overview Details

View History
  • Implied Volatility 76.55% ( +8.99%)
  • Historical Volatility 61.29%
  • IV Percentile 18%
  • IV Rank 16.18%
  • IV High 342.43% on 05/07/24
  • IV Low 25.22% on 02/13/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 120
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,813
  • Open Int (30-Day) 3,896

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +77.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.58 +41.82%
on 10/25/24
11.11 -3.24%
on 11/13/24
+2.31 (+27.37%)
since 10/21/24
3-Month
4.12 +160.92%
on 08/22/24
11.11 -3.24%
on 11/13/24
+6.61 (+159.66%)
since 08/21/24
52-Week
3.03 +254.79%
on 04/17/24
11.11 -3.24%
on 11/13/24
+7.20 (+202.82%)
since 11/21/23

Most Recent Stories

More News
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

ETON : 10.75 (+3.07%)
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

ETON : 10.75 (+3.07%)
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

ETON : 10.75 (+3.07%)
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

ETON : 10.75 (+3.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 10.75 (+3.07%)
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...

AZYO : 1.4900 (+2.05%)
SIEN : 0.1740 (-18.69%)
BIOL : 0.0174 (-71.98%)
BTCY : 0.2776 (-11.85%)
ETON : 10.75 (+3.07%)
SWKH : 15.25 (+0.59%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 10.75 (+3.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 10.75 (+3.07%)
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and...

AZYO : 1.4900 (+2.05%)
ACER : 0.6601 (-17.95%)
BIOL : 0.0174 (-71.98%)
BTCY : 0.2776 (-11.85%)
ETON : 10.75 (+3.07%)
SWKH : 15.25 (+0.59%)
Eton Pharmaceuticals Announces FDA Approval of ZONISADEâ„¢ (Zonisamide Oral Suspension)

DEER PARK, Ill., July 18, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing...

ETON : 10.75 (+3.07%)

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

3rd Resistance Point 11.54
2nd Resistance Point 11.16
1st Resistance Point 10.96
Last Price 10.75
1st Support Level 10.37
2nd Support Level 9.99
3rd Support Level 9.79

See More

52-Week High 11.11
Last Price 10.75
Fibonacci 61.8% 8.02
Fibonacci 50% 7.07
Fibonacci 38.2% 6.12
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar